Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 3654  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  » Next article
  » Previous article 
  » Table of Contents
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (138 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  


  In this Article
 »  Abstract
 »  Material and Methods
 »  Results
 »  Discussion
 »  Acknowledgments
 »  References

 Article Access Statistics
    Viewed5426    
    Printed159    
    Emailed8    
    PDF Downloaded168    
    Comments [Add]    
    Cited by others 5    

Recommend this journal

   
ORIGINAL ARTICLE
Year : 2003  |  Volume : 51  |  Issue : 1  |  Page : 13-15

Increased cortical excitability with longer duration of Parkinson’s disease as evaluated by transcranial magnetic stimulation


Department of Neurology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029.

Correspondence Address:
Department of Neurology, Neurosciences Centre, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029.
manvirbhatia@hotmail.com

 » Abstract 

Transcranial Magnetic Stimulation (TMS) was used to evaluate the cortical excitability and central motor pathways in Parkinson’s disease (PD) and correlate with severity and duration of disease. 19 cases of PD and 13 controls were enrolled. The threshold intensity (TI), cortical latency (CL), central conduction time (CCT), motor evoked potential amplitude (MEP) obtained with TMS were correlated with Hoehn and Yahr and duration of disease. The threshold intensity (TI) was significantly lower in patients of PD than controls. The TI in patients with PD was 53.16+ 8.4% patients and 67.1+21.6% in controls (p<0.05). This strongly correlated with duration of disease, TI being lower in patients with disease duration more than 5 years. There was no difference in the other TMS parameters – CL, CCT, MEP between patients and controls.Our study revealed increased excitability in PD which was related to longer duration of disease.

How to cite this article:
Bhatia M, Johri S, Behari M. Increased cortical excitability with longer duration of Parkinson’s disease as evaluated by transcranial magnetic stimulation. Neurol India 2003;51:13-5


How to cite this URL:
Bhatia M, Johri S, Behari M. Increased cortical excitability with longer duration of Parkinson’s disease as evaluated by transcranial magnetic stimulation. Neurol India [serial online] 2003 [cited 2020 Apr 2];51:13-5. Available from: http://www.neurologyindia.com/text.asp?2003/51/1/13/1021


Transcranial magnetic stimulation (TMS), originally described by Barker et al[1] has now evolved into a safe, non-invasive method of stimulating intact motor cortex in humans and thereby enabling assessment of conduction in central motor pathways and excitability of motor cortex.[2],[3] Several studies have been done to evaluate central motor circuitry in Parkinson's disease in an effort to understand the pathophysiologic mechanism.[4],[5] Reports of the previous studies of TMS in PD have been very heterogeneous with different parameters being evaluated by authors. The reports include an increase in amplitude of motor evoked potential (MEP) as compared to controls,[4],[6],[7] a decrease in latency on the rigid side,[8] decrease in threshold on more affected side, [3],[4],[9] an increase in threshold[10] while others reported changes in central motor conduction time.[4] The effect of duration and disease severity on these parameters has however not been adequately studied.
The aim of this study was to use TMS to study the motor cortex excitability and central conduction in patients with Parkinson's disease as compared with healthy controls.

  »   Material and Methods
 Top
We studied 19 patients with Parkinson's disease attending the Movement disorders clinic at the All India Institute of Medical Sciences, New Delhi, India between Jan 1997 to June 1998. The clinical diagnosis was as per the criteria by U.K. Parkinson's Disease Society Brain Bank clinical diagnostic criteria.[11] All subjects gave written informed consent prior to the study. Patients with poorly controlled tremors at rest, metallic implants such as cardiac pacemaker, intracranial aneurysmal clips, urinary bladder stimulator and metallic orthopedic implants, pregnant women, those with poorly controlled seizures and with severe on-off phenomenon were excluded. Controls included healthy volunteers and relatives of patients admitted in neurology ward. None had a prior history of neurologic disease or metallic implants.
Magnetic stimulation of cortex and cervical spine was done with D-190 circular magnetic coil (Digitimer Limited, Hertfordshire, U.K.) 9 cm,1.5 tesla with maximum coil energy of 1200 joules. Cortical stimulation was done with coil positioned tangential to skull, over the vertex in mid-saggital plane, dissecting the intraural line. The direction of current was anticlockwise for stimulation of right cortex and clockwise for stimulation of left cortex. Cervical stimulation was done with center of coil placed over 7th cervical spinal process. Stimuli were delivered as single shocks at least 5-10 seconds apart.[12]
Standard Medelec EMG machine (Oxford, UK) was used for recording MEP from abductor pollicis bevis (APB) by surface electrodes. Subjects were seated comfortably in a chair, with their arms in their lap and eyes open. Activation of APB was achieved by abduction of thumb to 450 against gravity. The threshold intensity, cortical latency, MEP amplitude and central conduction time on both sides in each patient and control were recorded.
Threshold Intensity (TI): This was determined for the relaxed muscle ensured by recovery EMG. TI was defined for each hemisphere, as lowest stimulation intensity required to evoke at least three reproducible MEPs out of five consecutive stimuli at rest with peak to peak amplitude of more than 50 micro volts,[12] at a sensitivity of 200 microvolts. Cortex was initially stimulated at 25% of maximum coil output. Intensity was increased in 5% increments with 5 stimuli given at each intensity. If no response was recorded at maximum output of 100%, then thumb was abducted to 450 for activation of target muscle. In the absence of response the TI was taken as 100%.[12]
Cortical Latency (CL): Cortical latency was determined with activation of target muscle. Five stimuli of 30% above T1 were given. CL was defined as shortest interval between time of stimulation and onset of first negative wave of MEP.
Cervical Latency (Cx): It is time taken by electrical stimuli to travel from spinal motor neurons to target muscle i.e. APB. Cx was determined by stimulating afferent roots at the C7 vertebral level.

Central Conduction Time (CCT):
CCT is calculated by deducting Cx latency from CL12
CCT= CL - Cx.
Statistical analysis was done using analytical software - 92, Statistic version 4.0. The mean and SD of TI, CL, MEP amplitude and CCT were compared in Parkinson's disease patients and controls, using t-test with p< 0.05 considered as significant. Intra-group analysis of PD patients was done to correlate the findings with duration of disease, stage of disease (H and Y) and type of Parkinson's disease ('tremor dominant' versus 'akinetic rigid type'), predominant side affected using rank-sum two sample (Mann Whitney) test.

  »   Results  Top


Transcranial magnetic stimulation (TMS) was done in 19 cases of Parkinson's disease and 13 controls. The mean age of PD patients was 56.5+10 years and 41+ 11 years in controls. TI was significantly lower on both sides in PD patients (p < 0.05) as compared to controls. There was no significant difference between patient and control on either side with respect to cortical latency (CL), amplitude of motor evoked potential (MEP amp), central conduction time (CCT) [Table - 1].
TMS analysis of 11 tremor dominant and 9 akinetic rigid patients revealed no significant difference in the parameters tested (TI, CL, MEP amplitude and CCT) on either side in the two groups.
Two subgroups were created signifying severity of disease. One group was with H and Y stage 1 and 1.5 i.e. unilateral disease (n=9): and second group with H and Y>2.
The TI, CL, CC and CCT revealed no significant difference.
14 patients out of 19 had predominant left-sided affection and 5 had right-sided affection.
There was no significant difference in any of the values on either side.
Patients with duration of symptoms less than 5 years (n=13) were compared with patients having duration of symptoms more than 5 years (n=6). TI was significantly less in patients with >5 years duration, signifying increased excitability of motor cortex as the disease advances [Table - 2].

  »   Discussion Top


In the present study the threshold index (TI) was significantly lower bilaterally in PD patients as compared to controls (P value <0.05). This has also been reported by Cantello et al.[6] The other parameters such as cortical latency (CL), motor evoked potential (MEP) amplitude and central conduction time (CCT) did not show a statistical difference when compared to controls.
The reports on TMS have heterogeneous findings. Kandler[4] has observed a decrease in CCT, however others [6],[9],[13] have found no change in CCT. The present study also did not find any difference in CCT in patients as compared to controls. Valls-Sole et al[8] and Ridding et al[5] have reported no difference in TI, but reported an increase in MEP amplitude, decrease in cortical latency (CL) and loss of facilitation with active contraction of muscle in PD patients as compared to controls.[8] On the other hand, Davey et al[10] and Ellaway et al[13] have reported increase in TI on more bradykinetic side in Parkinson's disease. There are only a few studies[4],[6] evaluating the relationship between disease severity, duration of disease and predominant type of PD (akinetic rigid vs. tremor dominant) with TMS parameters. Both the studies have reported decrease in TI in PD, but found different results of CCT. While Kandler[4] reported decrease in CCT in patients with predominant rigidity and bradykinesia, Cantello[6] found no significant change in CCT. The present study revealed no difference in any of the TMS parameters, including TI in the two broad clinical categories of 'tremor dominant PD' and 'akinetic rigid PD'. However, there was a consistent and significant correlation of TI, with disease duration. TI was found to be significantly lower in patients with disease duration more than five years (p<0.05) as compared to patients with disease duration less than five years. This may suggest that excitability increases with increasing duration of disease, however there was no difference on comparing with severity of disease.
An increase in MEP amplitude has been reported by some studies.[4],[6],[7] This was not observed in the present study. Various mechanisms have been proposed for the increased amplitude, such as increased facilitation. The pathophysiology of PD rigidity is largely obscure but together with other factors there may be excessive drive to alpha motor neurons (a-MNS) from supraspinal structures. Rubro-, reticulo- or vestibulo- spinal pathways could transmit this uncontrollable drive to a-MNS when released from basal ganglia, where the primitive dysfunction lies.
The clinical and electrophysiological significance and implications of these conflicting results are not clear. It appears that the relationship, which may exist between the electrophysiological abnormalities and individual clinical features and severity of disease, may be more complex or an expression of some other aspect of pathophysiology of PD which should be explored further.

  »   Acknowledgments Top


The authors acknowledge the technical assistance provided by R.S.Arya and M.S.Bisht and secretarial assistance by Laxmi Rawat.  

 » References Top

1.Barker AT, Jalinous R, Freesten IL. Non invasive magnetic stimulation of human motor cortex. Lancet. 1985;1:1106-7.  Back to cited text no. 1    
2.Rossini PM, Rossi S. Clinical application of motor evoked potentials. Electroencephal. Clin Neruophysiol 1998;106:180-94  Back to cited text no. 2  [PUBMED]  
3.Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from international workshop on the safety of repetitive transcranial magnetic stimulation. Electroencephal. Clin Neurophysiol 1998;108:1-16.  Back to cited text no. 3  [PUBMED]  
4.Kandler RH, Jarret JA, Sagar HJ, Gumpert EJW, Vinobles GS, Davies Jones GAB, and Jardon N. Abnormalities of Central Motor Conduction in Parkinson's Disease. J Neurol Sci 1990;100:94-7  Back to cited text no. 4    
5.Ridding MC, Inzelberg R, Rothwell JC. Changes in excitability of motor cortical circuitary in patients with Parkinson's Disease. Ann Neurol 1995;37:181-8.  Back to cited text no. 5  [PUBMED]  
6.Cantello R, Gianelli M, Bettucci D, Civardi C, De Angeles MS, Mutani R. Parkinson's Disease rigidity: magnetic motor evoked potential in a small hand muscle. Neurology 1991;41:1449-56.  Back to cited text no. 6    
7.Eisen A, Siejko S, Schulzer M, Calne D. Age dependent decline in motor evoked potential (MEP) amplitude: with a comment on changes in Parkinson's Disease. Electroencephal Clin Neurophysiol 1991;81:209-15.  Back to cited text no. 7    
8.Valls-Sole J, Pascual-Leone A, Brasil-Neto JP, Cammorota A, Mc Shane L, Hallet M. Abnormal facilitation of the response to magnetic stimulation in patients with Parkinson's Disease. Neurology 1994;44:735-41  Back to cited text no. 8    
9.Rossini PM, Paradise C, Zarda F, Bernardi G, Caramia MD, Margari L, Ferrari E. Brain excitability and long latency muscular arm responses: non invasive evaluation in healthy and Parkinsonism subject Electroencephal Clin Neurophysiol 1991;81:454-65.  Back to cited text no. 9    
10.Davey NJ, Dick JPR, Ellaway PH, Maskill DW. Raised motor cortical threshold associated with bradykinesia as revealed by transcranial magnetic stimulation in normal and Parkinson's Disease. J Physiol 1991;438:35.  Back to cited text no. 10    
11.Larsen JP, Dupont I, Tandberg E. Clinical diagnosis of Parkinson's Disease. Proposal of diagnostic subgroup classified at different levels of confidence. Acta Neurol Scan 1994;89:242-51.  Back to cited text no. 11    
12.Rossini PM, Barker AT, Berardelli A, Caramia MD, et al. Non invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephal Clin Neurophysiol 1994;91:79-92.  Back to cited text no. 12    
13.Ellaway PH, Davey NJ, Miekile DW, Dick JPR. The relation between bradykinesia and excitability of motor cortex assessed using transcranial magnetic stimulation in normal and Parkinsonian subjects. Electroencephal Clin Neurophysiol 1995;97:169-78  Back to cited text no. 13    

 

Top
Print this article  Email this article
Previous article Next article
Online since 20th March '04
Published by Wolters Kluwer - Medknow